Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 019892/0459 | |
| Pages: | 3 |
| | Recorded: | 09/28/2007 | | |
| Conveyance: | ASSIGNMENT OF SECURITY INTEREST |
|
|
Total properties:
8
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/04/1998
|
Application #:
|
07307366
|
Filing Dt:
|
02/06/1989
|
|
Title:
|
EXPRESSION SYSTEMS FOR AMIDATING ENZYME
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/15/1999
|
Application #:
|
08616250
|
Filing Dt:
|
03/15/1996
|
|
Title:
|
ORAL SALMON CALCITONIN PHARMACEUTICAL PRODUCTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/15/2000
|
Application #:
|
09060765
|
Filing Dt:
|
04/15/1998
|
|
Title:
|
DIRECT EXPRESSION OF PEPTIDES INTO CULTURE MEDIA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
07/11/2000
|
Application #:
|
09125500
|
Filing Dt:
|
08/19/1998
|
|
Title:
|
ORAL PEPTIDE PHARMACEUTICAL PRODUCTS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
04/03/2001
|
Application #:
|
09500009
|
Filing Dt:
|
02/08/2000
|
|
Title:
|
Direct expression of peptides into culture media
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
08/27/2002
|
Application #:
|
09776537
|
Filing Dt:
|
02/02/2001
|
|
Title:
|
NASAL CALCITONIN FORMULATIONS
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
05/18/2004
|
Application #:
|
09780643
|
Filing Dt:
|
02/09/2001
|
|
Publication #:
|
|
Pub Dt:
|
04/18/2002
| | | | |
|
Title:
|
DIRECT EXPRESSION OF PEPTIDES INTO CULTURE MEDIA
|
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/25/2002
|
Application #:
|
09780870
|
Filing Dt:
|
02/09/2001
|
|
Publication #:
|
|
Pub Dt:
|
07/19/2001
| | | | |
|
Title:
|
Process for preparation of sulfonylurea salts
|
|
|
Assignee
|
|
|
|
|
| 248 ANDREA DRIVE |
| ROCKAWAY, NEW JERSEY 07866 |
|
|
Correspondence name and address
|
| |
JAMES J. JOHNSTON
|
| |
CIRA CENTRE, 2929 ARCH STREET
|
| |
DECHERT LLP
|
| |
PHILADELPHIA, PA 19104-2808
|
Search Results as of:
09/23/2025 06:58 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
